7 HILLS INTERESTS LLC has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in Canada, EPO (European Patent Office) and Mexico. Its main competitors in its focus markets pharmaceuticals and biotechnology are ASCENDIS PHARMA ONCOLOGY DIV A/S, ANJI PHARMACEUTICALS INC and WILSON D TRAVIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Mexico | 2 | |
#4 | Singapore | 2 | |
#5 | United States | 2 | |
#6 | Australia | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Marathi Upendra K | 14 |
#2 | Vanderslice Peter | 9 |
#3 | Woodside Darren G | 9 |
#4 | Upendra K Marathi | 3 |
#5 | Peter Vanderslice | 2 |
#6 | Darren G Woodside | 2 |
Publication | Filing date | Title |
---|---|---|
US2020054600A1 | Pharmaceutical compositions and methods for systemic treatment of solid tumors | |
EP3288585A2 | Novel compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants | |
KR20170136651A | New compositions and methods for immunotherapy comprising small molecule integrin receptor-ligand agonist adjuvants | |
CA2954175A1 | Compositions and methods to improve adoptive cell therapies | |
CA2939512A1 | Compositions and methods to improve the homing and grafting of hematopoetic stem cells |